The benzodiazepine alprazolam(Xanax;Pfizer) is being obtained for non-medical use in the UK,particularly among young people,survey results published in the British Journal of Clinical Pharmacology show(4 June 2019).Researchers analysed data from 10,019 respondents to the 2017 RADARS Survey of Non-Medical Use of Prescription Drugs,providing a representative sample of the adult UK population.Overall,the estimated lifetime non-medical use of alprazolam was 0.32% compared with 1.30% for diazepam.Unlike diazepam,for which there was no effect of age on use,the rate of recent use(defined as the past 90 days) was highest among those aged 16-24 years(0.37%) and 25-34 years(0.14%);this was virtually nil in people aged 35 years and over.
展开▼
